SCHEMBL10253003

SCHEMBL10253003

CC1(C(F)(F)F)OC(NC23CC4CC(CC(C4)C2)C3)=NC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.39
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GABBR2 O75899 1/20 0.32
GABBR1 Q9UBS5 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31
CA13 Q8N1Q1 1/20 0.31
EPHX2 P34913 1/20 0.31
TP53 P04637 1/20 0.30
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30
HTT P42858 1/20 0.30
HSD17B10 Q99714 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1604874 0.85 HSD11B1 (0.36) HSD11B1
SCHEMBL5016900 0.77 HSD11B1 (0.46) HSD11B1ALDH1A1GABBR2GABBR1HTT
SCHEMBL1605875 0.74 HSD11B1 (0.43) HSD11B1TSHRALDH1A1LMNAL3MBTL1
SCHEMBL1606672 0.72 HSD11B1 (0.38) HSD11B1TSHRALDH1A1LMNAL3MBTL1
SCHEMBL5015286 0.70 HSD11B1 (0.41) HSD11B1ALDH1A1GAA
SCHEMBL1605299 0.64 HSD11B1 (0.34) HSD11B1TSHRALDH1A1LMNAL3MBTL1
SCHEMBL1606292 0.64 KMT2A (0.38) TSHRALDH1A1LMNAL3MBTL1CA12
SCHEMBL1605818 0.63 LMNA (0.35) TSHRALDH1A1LMNAL3MBTL1EPHX2
SCHEMBL5017231 0.62 HSD11B1 (0.47) HSD11B1ALDH1A1EPHX2
SCHEMBL1605344 0.62 HSD11B1 (0.41) HSD11B1TSHRALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010256-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010256-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD3B1, HSD17B1 HSD11B1 1/4885TSHR 2428/4885ALDH1A1 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.